Lapo Alinari
Director, OSUCCC Hematology Tissue Bank Shared Resource · OSUCCC – James
Credentials: · · · · ·
History
- Present
OSUCCC Hematology Tissue Bank Shared Resource · OSUCCC – James
- 2013–2016
Ohio State University Wexner Medical Center
- 2012–2013
Ohio State University Wexner Medical Center
- 2011–2012
Ohio State University Wexner Medical Center
- 2003–2007
S Orsola Malpighi Polyclinic
- 1999–2003
S Orsola Malpighi Polyclinic
- 1991–1998
Universita Degli Studi di Firenze
Research
Journal of Clinical Oncology · 2007 · 222 citations
Journal of Clinical Oncology · 2006 · 164 citations
Leukemia · 2016 · 148 citations
58 papers
19 papers
19 papers
19 papers · 1 as a fellow
18 papers · 2 as a fellow
- JB
18 papers
- YS
18 papers
17 papers
Grants
- 1997–2031
National Cancer Institute · P30
Project lead · $690.1K · Ohio State University
- 2023–2028
Trispecific CAR-T Cells Targeting CD19, CD20 and CD22 to Treat B-Cell Malignancies
National Cancer Institute · R01
PI · $2.4M · Ohio State University
- 2022–2027
Targeting c-Myc Stability in c-Myc Overexpressing Large B-Cell Lymphoma
National Cancer Institute · R01
Contact PI · $2.8M · Ohio State University
- 2018–2023
Targeting Transducin Beta-Like Protein 1 in Mantle Cell Lymphoma
National Cancer Institute · K08
Contact PI · $1.1M · Ohio State University
Clinical trials
- 2023–2028
Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma
Principal investigator · Recruiting · Phase 1
Lapo Alinari
- 2016–2026
Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Principal investigator · Active not recruiting · Phase 2
Ohio State University Comprehensive Cancer Center